Serum adiponectin level in diabetic patients with and without helicobacter pylori infection: Is there any difference?

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Vafaeimanesh, Jamshid ^a   Heidari, Akram ^a   Effatpanah, Marzieh ^a   Parham, Mahmoud ^a  

^a QOM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; IMMUNOGLOBULIN G ANTIBODY; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; HELICOBACTER INFECTION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN BLOOD LEVEL; SEROLOGY; BLOOD; COMPLICATION; HELICOBACTER PYLORI; RISK FACTOR;

ADIPONECTIN; ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84893178239     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/402685     Document Type: Article

References (28)

1. Bloomgarden Z. T., Measures of insulin sensitivity. Clinics in Laboratory Medicine 2006 26 3 611 633 2-s2.0-33747842503 10.1016/j.cll.2006.06.007 (Pubitemid 44287156)
2. Cefalu W. T., Insulin resistance: cellular and clinical concepts. Proceedings of the Society for Experimental Biology and Medicine 2001 226 1 13 26 2-s2.0-0035159865
3. Gruzdeva O., Uchasova E., Dyleva Y., Belik E., Shurygina E., Barbarash O., Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction. Diabetes, Metabolic Syndrome and Obesity 2013 6 293 301 10.2147/DMSO.S46627
4. Patel P. S., Buras E. D., Balasubramanyam A., The role of the immune system in obesity and insulin resistance. Journal of Obesity 2013 2013 9 616193 10.1155/2013/616193
5. Rothenbacher D., Brenner H., Burden of Helicobacter pylori and H. pylori -related diseases in developed countries: recent developments and future implications. Microbes and Infection 2003 5 8 693 703 2-s2.0-0038240648 10.1016/S1286-4579(03)00111-4 (Pubitemid 36695144)
6. Lin Y. L., Chiang J. K., Lin S. M., Tseng C. E., Helicobacter pylori infection concomitant with metabolic syndrome further increase risk of colorectal adenomas. World Journal of Gastroenterology 2010 16 30 3841 3846 2-s2.0-77955767264 10.3748/wjg.v16.i30.3841
7. Aydemir S., Bayraktaroglu T., Sert M., Sokmen C., Atmaca H., Mungan G., Gun B. D., Borazan A., Ustundag Y., The effect of Helicobacter pylori on insulin resistance. Digestive Diseases and Sciences 2005 50 11 2090 2093 2-s2.0-27144440828 10.1007/s10620-005-3012-z (Pubitemid 41504094)
8. So W. Y., Tong P. C., Ko G. T., Ma R. C., Ozaki R., Kong A. P., Yang X., Ho C., Lam C. C., Chan J. C., Low plasma adiponectin level, white blood cell count and Helicobacter pylori titre independently predict abnormal pancreatic β -cell function. Diabetes Research and Clinical Practice 2009 86 2 89 95 2-s2.0-70349782240 10.1016/j.diabres.2009.08.010
9. Papamichael K. X., Papaioannou G., Karga H., Roussos A., Mantzaris G. J., Helicobacter pylori infection and endocrine disorders: is there a link? World Journal of Gastroenterology 2009 15 22 2701 2707 2-s2.0-67651159073 10.3748/wjg.15.2701
10. Agrawal R. P., Sharma R., Garg D., Pokharna R., Kochar D. K., Kothari R. P., Role of Helicobacter pylori in causation of diabetic gastropathies and non-gastrointestinal complications in type 2 diabetes. Journal of the Indian Medical Association 2010 108 3 140 143 2-s2.0-77957671516
11. Aslan M., Horoz M., Nazligul Y., Bolukbas C., Bolukbas F. F., Selek S., Celik H., Erel O., Insulin resistance in H pylori infection and its association with oxidative stress. World Journal of Gastroenterology 2006 12 42 6865 6868 2-s2.0-33751353925 (Pubitemid 44811411)
12. Gillum R. F., Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the third national health and nutrition examination survey. Journal of the National Medical Association 2004 96 11 1470 1476 2-s2.0-8344235956 (Pubitemid 39482993)
13. Ozdem S., Akcam M., Yilmaz A., Artan R., Insulin resistance in children with Helicobacter pylori infection. Journal of Endocrinological Investigation 2007 30 3 236 240 2-s2.0-34250669984 (Pubitemid 46929324)
14. Eshraghian A., Hashemi S. A., Jahromi A. H., Eshraghian H., Masoompour S. M., Davarpanah M. A., Eshraghian K., Taghavi S. A., Helicobacter pylori infection as a risk factor for insulin resistance. Digestive Diseases and Sciences 2009 54 9 1966 1970 2-s2.0-68249160053 10.1007/s10620-008-0557-7
15. Gen R., Demir M., Ataseven H., Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. Southern Medical Journal 2010 103 3 190 196 2-s2.0-77949370995 10.1097/SMJ.0b013e3181cf373f
16. Zhou X., Zhang C., Wu J., Zhang G., Association between Helicobacter pylori infection and diabetes mellitus: a meta-analysis of observational studies. Diabetes Research and Clinical Practice 2013 99 2 200 208 10.1016/j.diabres.2012.11.012
17. Polyzos S. A., Kountouras J., Zavos C., Deretzi G., The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter 2011 16 2 79 88 2-s2.0-79952733679 10.1111/j.1523-5378. 2011.00822.x
18. Akanuma M., Yanai A., Sakamoto K., Hirata Y., Yamaji Y., Kawazu S., Maeda S., Influence of Helicobacter pylori eradication on the management of type 2 diabetes. Hepato-Gastroenterology 2012 59 114 641 645 2-s2.0-84860591035 10.5754/hge11960
19. Naja F., Nasreddine L., Hwalla N., Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults. Helicobacter 2012 17 6 444 451 10.1111/j.1523-5378.2012.00970.x
20. Renaldi O., Pramono B., Sinorita H., Purnomo L. B., Asdie R. H., Asdie A. H., Hypoadiponectinemia: a risk factor for metabolic syndrome. Acta Medica Indonesiana 2009 41 1 20 24 2-s2.0-77952515176
21. Tang C. H., Chiu Y. C., Tan T. W., Yang R. S., Fu W. M., Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF- B pathway. Journal of Immunology 2007 179 8 5483 5492 2-s2.0-38449089987
22. Díez J. J., Iglesias P., The role of the novel adipocyte-derived hormone adiponectin in human disease. European Journal of Endocrinology 2003 148 3 293 300 2-s2.0-0037356826 10.1530/eje.0.1480293 (Pubitemid 36410714)
23. Lihn A. S., Pedersen S. B., Richelsen B., Adiponectin: action, regulation and association to insulin sensitivity. Obesity Reviews 2005 6 1 13 21 2-s2.0-12444304182 10.1111/j.1467-789X.2005.00159.x
24. Ostrowska L., Fiedorczuk J., Adamska E., Effect of diet and other factors on serum adiponectin concentrations in patients with type 2 diabetes. Roczniki Państwowego Zakładu Higieny 2013 64 1 61 66
25. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R. E., Tataranni P. A., Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 2001 86 5 1930 1935 2-s2.0-0034999667 10.1210/jc.86.5.1930 (Pubitemid 32472900)
26. Hung J., McQuillan B. M., Thompson P. L., Beilby J. P., Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. International Journal of Obesity 2008 32 5 772 779 2-s2.0-43449090395 10.1038/sj.ijo.0803793 (Pubitemid 351670618)
27. Ando T., Ishikawa T., Takagi T., Imamoto E., Kishimoto E., Okajima A., Uchiyama K., Handa O., Yagi N., Kokura S., Naito Y., Mizuno S., Asakawa A., Inui A., Yoshikawa T., Impact of Helicobacter pylori eradication on circulating adiponectin in humans. Helicobacter 2013 18 2 158 164 10.1111/hel.12028
28. Hainer V., Hainerová I. A., Zamrazilová H., Role of infection in the pathogenesis of obesity Casopis Lékaru Ceských 2012 151 12 563 567